Molecular Designs, a developer and manufacturer of molecular infectious disease assays, today announced it has submitted a ...
Quality Control Market Size is projected to grow at a CAGR of 6.66 Market Research®. The report reveals that the market was ...
Zacks Investment Research on MSN
QuidelOrtho Expands Portfolio With the Launch of FDA-Approved Test
Last week, QuidelOrtho Corporation QDEL announced the availability of QUICKVUE Influenza + SARS Test. The CLIA-waived, 510(k)–cleared rapid, easy-to-use immunoassay is the latest addition to the ...
SALT LAKE CITY--(BUSINESS WIRE)--Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced ...
Strategic Investor, Osang Healthcare will partner with Kryptos Biotechnologies for the manufacturing and distribution of the product along with financing. “We are thrilled to receive the trust and ...
Vector Smart™ NAM-e multiplex PCR test to provide proactive defense against mosquito populations carrying the deadly eastern equine encephalitis virus SALT LAKE CITY--(BUSINESS WIRE)-- Co-Diagnostics, ...
GARDENA, CALIFORNIA / ACCESS Newswire / September 25, 2025 / OPEN Healthcare proudly announces the grand opening of its new state-of-the-art 23,000-square-foot clinical laboratory in Gardena, ...
Researchers have introduced a molecular switch that could control when drugs are active or inactive in the body.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback